Your browser doesn't support javascript.
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
Grunau, Brian; Goldfarb, David M; Asamoah-Boaheng, Michael; Golding, Liam; Kirkham, Tracy L; Demers, Paul A; Lavoie, Pascal M.
  • Grunau B; Department of Emergency Medicine, University of British Columbia, Vancouver, Canada.
  • Goldfarb DM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Asamoah-Boaheng M; Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada.
  • Golding L; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
  • Kirkham TL; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Demers PA; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Lavoie PM; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
JAMA ; 327(3): 279-281, 2022 01 18.
Article in English | MEDLINE | ID: covidwho-1669284

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization Schedule / SARS-CoV-2 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 Topics: Vaccines Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2021.21921

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization Schedule / SARS-CoV-2 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 Topics: Vaccines Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article Affiliation country: Jama.2021.21921